<DOC>
	<DOC>NCT00488488</DOC>
	<brief_summary>To assess the efficacy and safety of Tygacil in the usual German hospital setting. The main goals are: to assess the efficacy of Tygacil under usual care conditions (cure rate); to assess the main side effects observed in daily medical practice (Safety of Tygacil); to determine whether patients are optimally dosed with Tygacil (according to the label) and the proportion of patients receiving a monotherapy versus combination therapy; to observe the potential resistance development against Tygacil in Germany; to determine which antibiotic agents are chosen for a combination therapy with Tygacil; to determine to which antibiotic substance non-responders to Tygacil are switched; to assess the duration of the intravenous therapy with Tygacil and to determine whether and which patients receive an oral antibiotic substance after the therapy with Tygacil; to collect information on profile, comorbidities and characteristics of patients treated with Tygacil.</brief_summary>
	<brief_title>A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting</brief_title>
	<detailed_description>Non-interventional study: subjects to be selected according to the usual clinical practice of their physician.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<criteria>Actual or planned therapy with tigecycline. At least 18 years old. Hypersensitivity to antibiotics or tigecycline.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>